These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16545341)

  • 1. Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor.
    Boisseau S; Mabrouk K; Ram N; Garmy N; Collin V; Tadmouri A; Mikati M; Sabatier JM; Ronjat M; Fantini J; De Waard M
    Biochim Biophys Acta; 2006 Mar; 1758(3):308-19. PubMed ID: 16545341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane.
    Estève E; Mabrouk K; Dupuis A; Smida-Rezgui S; Altafaj X; Grunwald D; Platel JC; Andreotti N; Marty I; Sabatier JM; Ronjat M; De Waard M
    J Biol Chem; 2005 Apr; 280(13):12833-9. PubMed ID: 15653689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells.
    Estève E; Smida-Rezgui S; Sarkozi S; Szegedi C; Regaya I; Chen L; Altafaj X; Rochat H; Allen P; Pessah IN; Marty I; Sabatier JM; Jona I; De Waard M; Ronjat M
    J Biol Chem; 2003 Sep; 278(39):37822-31. PubMed ID: 12869557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanism.
    Chen L; Estève E; Sabatier JM; Ronjat M; De Waard M; Allen PD; Pessah IN
    J Biol Chem; 2003 May; 278(18):16095-106. PubMed ID: 12586831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of the cell penetrating properties of an iodinated Tyr-L-maurocalcine analog.
    Tisseyre C; Ahmadi M; Bacot S; Dardevet L; Perret P; Ronjat M; Fagret D; Usson Y; Ghezzi C; De Waard M
    Biochim Biophys Acta; 2014 Oct; 1843(10):2356-64. PubMed ID: 24667409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical amino acid residues of maurocalcine involved in pharmacology, lipid interaction and cell penetration.
    Mabrouk K; Ram N; Boisseau S; Strappazzon F; Rehaim A; Sadoul R; Darbon H; Ronjat M; De Waard M
    Biochim Biophys Acta; 2007 Oct; 1768(10):2528-40. PubMed ID: 17888395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charged surface area of maurocalcine determines its interaction with the skeletal ryanodine receptor.
    Lukács B; Sztretye M; Almássy J; Sárközi S; Dienes B; Mabrouk K; Simut C; Szabó L; Szentesi P; De Waard M; Ronjat M; Jóna I; Csernoch L
    Biophys J; 2008 Oct; 95(7):3497-509. PubMed ID: 18621823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maurocalcine interacts with the cardiac ryanodine receptor without inducing channel modification.
    Altafaj X; France J; Almassy J; Jona I; Rossi D; Sorrentino V; Mabrouk K; De Waard M; Ronjat M
    Biochem J; 2007 Sep; 406(2):309-15. PubMed ID: 17537000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine.
    Ram N; Aroui S; Jaumain E; Bichraoui H; Mabrouk K; Ronjat M; Lortat-Jacob H; De Waard M
    J Biol Chem; 2008 Aug; 283(35):24274-84. PubMed ID: 18603532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of maurocalcine on Ca2+ release events and depolarization-induced Ca2+ release in rat skeletal muscle.
    Szappanos H; Smida-Rezgui S; Cseri J; Simut C; Sabatier JM; De Waard M; Kovács L; Csernoch L; Ronjat M
    J Physiol; 2005 Jun; 565(Pt 3):843-53. PubMed ID: 15831537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca(2+) release channel/ryanodine receptors.
    Fajloun Z; Kharrat R; Chen L; Lecomte C; Di Luccio E; Bichet D; El Ayeb M; Rochat H; Allen PD; Pessah IN; De Waard M; Sabatier JM
    FEBS Lett; 2000 Mar; 469(2-3):179-85. PubMed ID: 10713267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient loss of voltage control of Ca2+ release in the presence of maurocalcine in skeletal muscle.
    Pouvreau S; Csernoch L; Allard B; Sabatier JM; De Waard M; Ronjat M; Jacquemond V
    Biophys J; 2006 Sep; 91(6):2206-15. PubMed ID: 16782801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new fold in the scorpion toxin family, associated with an activity on a ryanodine-sensitive calcium channel.
    Mosbah A; Kharrat R; Fajloun Z; Renisio JG; Blanc E; Sabatier JM; El Ayeb M; Darbon H
    Proteins; 2000 Aug; 40(3):436-42. PubMed ID: 10861934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-sensitive stimulation of type-1 ryanodine receptors by the scorpion toxin maurocalcine.
    Ronjat M; Finkelstein JP; Llanos P; Montecinos L; Bichraoui H; De Waard M; Hidalgo C; Bull R
    Cell Calcium; 2013; 53(5-6):357-65. PubMed ID: 23623374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new scorpion toxin (BmK-PL) stimulates Ca2+-release channel activity of the skeletal-muscle ryanodine receptor by an indirect mechanism.
    Kuniyasu A; Kawano S; Hirayama Y; Ji YH; Xu K; Ohkura M; Furukawa K; Ohizumi Y; Hiraoka M; Nakayama H
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):343-50. PubMed ID: 10191265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In cellulo phosphorylation induces pharmacological reprogramming of maurocalcin, a cell-penetrating venom peptide.
    Ronjat M; Feng W; Dardevet L; Dong Y; Al Khoury S; Chatelain FC; Vialla V; Chahboun S; Lesage F; Darbon H; Pessah IN; De Waard M
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2460-8. PubMed ID: 27071086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of the high-affinity activation of type 1 ryanodine receptors by imperatoxin A.
    Lee CW; Lee EH; Takeuchi K; Takahashi H; Shimada I; Sato K; Shin SY; Kim DH; Kim JI
    Biochem J; 2004 Jan; 377(Pt 2):385-94. PubMed ID: 14535845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptor.
    Altafaj X; Cheng W; Estève E; Urbani J; Grunwald D; Sabatier JM; Coronado R; De Waard M; Ronjat M
    J Biol Chem; 2005 Feb; 280(6):4013-6. PubMed ID: 15591063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recombinant dihydropyridine receptor II-III loop and partly structured 'C' region peptides modify cardiac ryanodine receptor activity.
    Dulhunty AF; Karunasekara Y; Curtis SM; Harvey PJ; Board PG; Casarotto MG
    Biochem J; 2005 Feb; 385(Pt 3):803-13. PubMed ID: 15511220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-Maurocalcine, a pharmacologically inert efficient cell-penetrating peptide analogue.
    Poillot C; Dridi K; Bichraoui H; Pêcher J; Alphonse S; Douzi B; Ronjat M; Darbon H; De Waard M
    J Biol Chem; 2010 Oct; 285(44):34168-80. PubMed ID: 20610396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.